4//SEC Filing
ARGOS THERAPEUTICS INC 4
Accession 0001209191-14-009871
CIK 0001105533operating
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 6:24 PM ET
Size
11.0 KB
Accession
0001209191-14-009871
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Stock
2014-02-12+1,859→ 6,800 total - Conversion
Series D Preferred Stock
2014-02-12−4,941→ 0 total→ Common Stock (4,941 underlying) - Conversion
Common Stock
2014-02-12+4,941→ 4,941 total - Conversion
Series E Preferred Stock
2014-02-12−1,859→ 0 total→ Common Stock (1,859 underlying)
Footnotes (2)
- [F1]Each share of Series D Preferred Stock converted into 0.1667 shares of common stock upon the closing of the Issuer's initial public offering of common stock for no additional consideration. The Series D Preferred Stock has no expiration date.
- [F2]Each share of Series E Preferred Stock converted into 0.1667 shares of common stock upon the closing of the Issuer's initial public offering of common stock for no additional consideration. The Series E Preferred Stock has no expiration date.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001105533
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 6:24 PM ET
- Size
- 11.0 KB